Vol 2, No 3 (2006)

May/June

Table of Contents

Articles

Reality and responsibility: A commentary on the treatment of pain and suffering in a drug-using society
Steven D. Passik, PhD, Howard Heit, MD, FACP, FASAM, Kenneth L. Kirsh, PhD
PDF
123-127
Pain control for dying patients: Hastening death or ensuring comfort?
Marshall B. Kapp, JD, MPH
PDF
128-129
Modafinil: Is it ready for prime time?
Eric Prommer, MD
PDF
130-136
Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain
Randall T. Brown, MD, Megan Zuelsdorff, BS, Michael Fleming, MD, MPH
PDF
137-146
Opioids and brain imaging
Shyam Balasubramanian, MBBS, MD, FRCA, Patricia Morley-Forster, MD, FRCPC, Yves Bureau, PhD
PDF
147-153
The ACTION study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA®) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin®) for the treatment of chronic, moderate to severe low back pain
Richard L. Rauck, MD, Stephen A. Bookbinder, MD, Timothy R. Bunker, MD, Christopher D. Alftine, MD, Richard Ghalie, MD, Andres Negro-Vilar, MD, PhD, Egbert de Jong, MD, Steven Gershon, MD
PDF
155-166
A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008—a long-acting, parenteral opioid analgesic—in the treatment of postherpetic neuralgia
Mark S. Wallace, MD, Dwight Moulin, MD, A. J. M. Clark, FRCPC, Ronald Wasserman, MD, Ann Neale, Patricia Morley-Forster, MD, Jean-Paul Castaigne, MD, Sam Teichman, MD
PDF
167-173

Case Studies

Morphine toxicity in renal failure
Ferraz Gonçalves, MD
PDF
174-176

ICOO Conference Information

Inaugural Opioid Certification Program
 
PDF
120-121

Full Issue

MAY/JUNE 2006
 
PDF
113-176

Calendar

Calendar
Richard A. DeVito, Jr.
PDF
122